Nav1.9 is a tetrodotoxin-resistant voltage-gated sodium channel encoded by SCN11A, with predominant expression in small-diameter nociceptive primary afferents and enteric/peripheral sensory circuits.[1][2] Compared with fast-spiking Nav channels, Nav1.9 produces a persistent, low-threshold sodium current that strongly modulates resting membrane potential and subthreshold excitability in pain pathways.[1:1][3]
In translational neuroscience, Nav1.9 is a key model for linking ion-channel biophysics to human sensory phenotypes ranging from severe pain to relative pain insensitivity.[2:1][4]
Nav1.9 uses the standard Nav domain layout (DI-DIV, S1-S6 repeats), but its gating kinetics are unusual:
Because Nav1.9 acts as an excitability amplifier rather than only a spike initiator, modest functional shifts can generate large clinical effects in inflammatory or neuropathic states.[1:3][3:2]
SCN11A variants produce a bidirectional phenotype spectrum:[2:3][4:1][5]
This “painful vs painless channelopathy” framework is now central to sodium-channel precision medicine.[4:2][5:1]
Nav1.9 is primarily a peripheral sensory channel, not a first-line AD/PD pathogenic protein. Still, it remains relevant to neurodegeneration care pathways:
For disease-network context, see nociceptors, ion channel dysfunction in neurodegeneration, and sodium channel blockers for neurodegeneration.
Nav1.9 remains a high-value but technically challenging analgesic target.[1:5][3:3]
Dib-Hajj SD, Yang Y, Black JA, Waxman SG. NaV1.9: a sodium channel linked to human pain. Nature Reviews Neuroscience. 2015. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Painful and painless channelopathies. Lancet Neurology. 2014. ↩︎ ↩︎ ↩︎ ↩︎
Martins DF, Mazzardo-Martins L, Cidral-Filho FJ, et al. The voltage-gated sodium channel NaV1.9 in visceral pain. Pflugers Archiv. 2016. ↩︎ ↩︎ ↩︎ ↩︎
Leipold E, Liebmann L, Korenke GC, et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nature Genetics. 2013. ↩︎ ↩︎ ↩︎
Han C, Vasylyev D, Macala LJ, et al. The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivity. The Journal of Neuroscience. 2006. ↩︎ ↩︎ ↩︎
Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels. Pflugers Archiv. 2020. ↩︎